Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Centre Hospitalier du Mans · Université Paris Cité · +2 more institutions
Abstract
Since testing for antineutrophil cytoplasmic antibodies (ANCA) became available for routine evaluation, no large homogeneous cohort of patients with the Churg-Strauss syndrome has been studied.
To define the clinical and biological characteristics of newly diagnosed Churg-Strauss syndrome, according to the presence or absence of ANCA.
Citation impact
- FWCI
- 20.82
- Percentile
- 100%
- References
- 29
Authors
15- RSR. Sablé-FourtassouCorresponding
Centre Hospitalier du Mans, Université Paris Cité, Addenbrooke's Hospital, Hôpital Cochin
- PCPascal Cohen
Hôpital Cochin, Centre Hospitalier du Mans, Université Paris Cité, Addenbrooke's Hospital
- AMAlfred Mahr
Centre Hospitalier du Mans, Hôpital Cochin, Université Paris Cité, Addenbrooke's Hospital
- CPChristian Pagnoux
Université Paris Cité, Addenbrooke's Hospital, Hôpital Cochin, Centre Hospitalier du Mans
- LMLuc Mouthon
Addenbrooke's Hospital, Centre Hospitalier du Mans, Hôpital Cochin, Université Paris Cité
Topics & keywords
- Medicine
- Churg-strauss syndrome
- Anti-neutrophil cytoplasmic antibody
- Antibody
- Immunology
- Vasculitis
- Pathology
- Disease
- Good health and well-being